Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Corticotropin-Releasing Factor Receptor 2 (CRF2) is a G protein-coupled receptor that modulates stress responses both centrally and peripherally. It is activated by urocortins and corticotropin-releasing hormone (CRH), leading to downstream signaling events. It is expressed in various tissues, including the brain, heart, skeletal muscle, and gastrointestinal tract, and plays a role in cardiovascular function, gastric motility, and stress adaptation. Selective antagonists like astressin-II B and antisauvagine–30 are useful tools for research and potential therapeutics.
Activation of G proteins (primarily Gs), leading to adenylate cyclase activation and downstream signaling events.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corticotropin-Releasing Factor Receptor 2 (CRF2).